cefoperazone has been researched along with Neoplasms in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (52.17) | 18.7374 |
1990's | 6 (26.09) | 18.2507 |
2000's | 1 (4.35) | 29.6817 |
2010's | 4 (17.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J | 1 |
Arda, B; Nazli-Zeka, A; Ozkoren-Calik, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T | 1 |
Sadikot, RT; Swenson, CE | 1 |
Emecen, M; Erdem, E; Karaman, S; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
Mitrokhin, SD | 1 |
Chiarini, F; Del Piano, M; La Palombara, P; Nicosia, R | 1 |
Klastersky, J; Moody, M; Schimpff, SC; Standiford, HC; Tatem, B; Viollier, AF | 1 |
Bodey, GP; Brown, NS; Ho, DH; LeBlanc, BM; Maksymiuk, AW | 1 |
Klastersky, J; Lagast, H; Meunier, F; Piccart, M; Van Laethem, Y; Weerts, D | 1 |
Benjamin, R; Bodey, GP; Elting, LS; Estey, E; Koller, C; Narro, J; O'Brien, S | 1 |
Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
Amako, Y; Fujisaki, M; Hirano, M; Ishii, J; Itakura, M; Iwasa, T; Kako, M; Koyama, M; Mitamura, K; Nakaya, S; Nishio, T; Ohswawa, N; Ohyama, R; Okuda, K; Oohira, S; Saito, H; Shinagawa, N; Sugiyama, A; Takashima, S; Takeda, S; Ueda, M; Yamada, M; Yasuda, Y; Zeze, F | 1 |
Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
Bodey, G; Elting, L; Hagemeister, F; Kantarjian, H; Keating, M; Koller, C; Papadopoulos, N; Reuben, A; Velasquez, W | 1 |
Anaissie, EJ; Bodey, GP; Fainstein, V; Jones, PG; Khardori, NM; Rolston, KV; Steelhammer, L | 1 |
Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
Gucalp, R; Lia, S; McKitrick, JC; Wiernik, PH | 1 |
Bodey, GP; Elting, L; Ho, DH | 1 |
Klastersky, J | 1 |
Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J | 1 |
Bodey, GP; Fainstein, V; Jones, P; Riccardi, S; Rolston, K | 1 |
Bodey, P; Hsi Ho, D; Rolston, K | 1 |
Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Strother, SV | 1 |
2 review(s) available for cefoperazone and Neoplasms
Article | Year |
---|---|
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
Cefoperazone in the treatment of infections in cancer patients.
Topics: Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms | 1988 |
15 trial(s) available for cefoperazone and Neoplasms
Article | Year |
---|---|
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult | 2018 |
Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Time Factors | 2012 |
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1984 |
An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Sulbactam | 1993 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
[Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Cholangitis; Cholecystitis; Drug Combinations; Enterococcus; Female; Humans; Klebsiella Infections; Liver Abscess; Male; Middle Aged; Neoplasms; Pseudomonas Infections; Sulbactam; Treatment Outcome | 1997 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.
Topics: Aztreonam; Bacterial Infections; Cefoperazone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neoplasms; Neutropenia | 1991 |
Single agent therapy for infections in cancer patients: a prospective randomized trial comparing three extended-spectrum cephalosporins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Ceftizoxime; Ceftriaxone; Costs and Cost Analysis; Drug Administration Schedule; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Pneumonia; Prospective Studies; Remission Induction | 1991 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Cefoperazone plus tobramycin versus ticarcillin plus tobramycin in febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin; Tobramycin | 1988 |
Cefoperazone in the treatment of infections in cancer patients.
Topics: Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms | 1988 |
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins | 1988 |
Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukocyte Count; Male; Mezlocillin; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutrophils | 1988 |
Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillin.
Topics: Carotenoids; Cefoperazone; Clinical Trials as Topic; Creatinine; Drug Therapy, Combination; Factor VII; Humans; Hypoprothrombinemias; Mezlocillin; Neoplasms; Prealbumin; Prothrombin Time; Random Allocation; Time Factors | 1986 |
7 other study(ies) available for cefoperazone and Neoplasms
Article | Year |
---|---|
Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sulbactam; Treatment Outcome | 2014 |
[Sulperazone in the treatment of severe infections in patients with cancer].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neoplasms; Pneumonia, Bacterial; Sulbactam; Surgical Wound Infection; Urinary Tract Infections | 2003 |
Activity of some antibiotics against Pseudomonas aeruginosa strains isolated from cancerous patients.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Drug Resistance, Microbial; Humans; Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections | 1984 |
Antibiotic combinations against gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlocillin singly or combined together.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Staphylococcus aureus | 1982 |
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Female; Half-Life; Humans; Kinetics; Male; Middle Aged; Neoplasms | 1981 |
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Ciprofloxacin; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Thienamycins | 1988 |
Cefoperazone for infections in cancer patients.
Topics: Bacterial Infections; Cefoperazone; Ceftizoxime; Ceftriaxone; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Neoplasms | 1987 |